| Nome |
# |
|
History of L-carnitine: Implications for renal disease, file de3e52ae-a595-762d-e053-3705fe0a30e0
|
12
|
|
Ego strength and health: An empiric study in hemodialysis patients, file de3e52ae-eb70-762d-e053-3705fe0a30e0
|
5
|
|
null, file de3e52b0-3479-762d-e053-3705fe0a30e0
|
5
|
|
Pain in end-stage renal disease: a frequent and neglected clinical problem., file de3e52ae-f444-762d-e053-3705fe0a30e0
|
4
|
|
The concept of the urine test and specific reaction of the urine in various diseases according to Enrico Cauchi - member of the medical council of Malta (1933), file de3e52b0-361e-762d-e053-3705fe0a30e0
|
4
|
|
[Management of hyperphosphatemia in patients with chronic kidney disease], file de3e52b0-5b94-762d-e053-3705fe0a30e0
|
4
|
|
Expert opinion of nephrologists about the effectiveness of low-protein diet in different stages of chronic kidney disease (CKD), file de3e52ae-a031-762d-e053-3705fe0a30e0
|
3
|
|
Extracellular Matrix Abnormality May be resposible for Cyst Development, file de3e52ae-a14b-762d-e053-3705fe0a30e0
|
3
|
|
How Much are Biosimilars Used in Southern Italy?: A Retrospective Analysis of Epoetin Utilization in the Local Health Unit of Messina in the Years 2010-2011., file de3e52ae-d223-762d-e053-3705fe0a30e0
|
3
|
|
Erythropoiesis-stimulating agents: dose and mortality risk, file de3e52af-36d2-762d-e053-3705fe0a30e0
|
3
|
|
Nursing and quality of life in CKD (Chronic Kidney Desease), file de3e52ae-adbe-762d-e053-3705fe0a30e0
|
2
|
|
Pharmacological treatment of acute and chronic hyperuricemia in kidney diseased patients., file de3e52ae-add2-762d-e053-3705fe0a30e0
|
2
|
|
Nutritional therapy in chronic kidney disease, file de3e52ae-add3-762d-e053-3705fe0a30e0
|
2
|
|
L-arginine: a new opportunity in the management of clinical derangements in dialysis patients., file de3e52ae-b900-762d-e053-3705fe0a30e0
|
2
|
|
The discovery of nephrouroameba: Was it real or not?, file de3e52ae-be5d-762d-e053-3705fe0a30e0
|
2
|
|
Uremic autonomic neuropathy studied by spectral analysis of heart rate, file de3e52ae-c146-762d-e053-3705fe0a30e0
|
2
|
|
Endothelial dysfunction in chronic renal failure., file de3e52ae-c9a0-762d-e053-3705fe0a30e0
|
2
|
|
Infezioni Delle Vie Urinarie e Tubercolosi Urinaria, file de3e52ae-ce27-762d-e053-3705fe0a30e0
|
2
|
|
L-Carnitine in hemodialysis patients, file de3e52ae-e1fc-762d-e053-3705fe0a30e0
|
2
|
|
Phosphate salivary secretion in hemodialysis patients : implications for treatment of hyperphosphatemia, file de3e52ae-e95c-762d-e053-3705fe0a30e0
|
2
|
|
The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care., file de3e52ae-ead5-762d-e053-3705fe0a30e0
|
2
|
|
Medication is an additional source of phosphate intake in chronic kidney disease patients, file de3e52b0-4766-762d-e053-3705fe0a30e0
|
2
|
|
Autonomic dysfunction in uremia, file de3e52ae-a444-762d-e053-3705fe0a30e0
|
1
|
|
Effects of manidipine and nifedipine on blood pressure and renal function in patients with chronic renal failure: A multicenter randomized controlled trial, file de3e52ae-a596-762d-e053-3705fe0a30e0
|
1
|
|
Epidemiology of hepatitis C virus infection in hemodialysis patients of Sicily, file de3e52ae-adba-762d-e053-3705fe0a30e0
|
1
|
|
Therapy of kidney diseases in poor people in France during the 18th century., file de3e52ae-add4-762d-e053-3705fe0a30e0
|
1
|
|
Anticardiolipin antibodies in hemodialysis patients and in renal transplant recipients: prevalence and significance, file de3e52ae-add7-762d-e053-3705fe0a30e0
|
1
|
|
Ultrastructural changes of corpora cavernosa in men with erectile dysfunction and chronic renal failure, file de3e52ae-b1fe-762d-e053-3705fe0a30e0
|
1
|
|
Phosphate binders and management of hyperphosphataemia in end-stage renal disease, file de3e52ae-b305-762d-e053-3705fe0a30e0
|
1
|
|
L-carnitine infusions may suppress serum C-reactive protein and improve nutritional status in maintenance hemodialysis patients, file de3e52ae-b31a-762d-e053-3705fe0a30e0
|
1
|
|
Sexual dysfunction in chronic renal failure, file de3e52ae-b3bf-762d-e053-3705fe0a30e0
|
1
|
|
A new approach to the evaluation of hyperphosphatemia in chronic kidney disease, file de3e52ae-b525-762d-e053-3705fe0a30e0
|
1
|
|
Systemic involvement and uremia in a patient with tuberous sclerosis, file de3e52ae-b527-762d-e053-3705fe0a30e0
|
1
|
|
Exhaustion of vascular endowment in hemodialysis: proposal for a permanent inlet access, file de3e52ae-b703-762d-e053-3705fe0a30e0
|
1
|
|
Ethylene oxide allergy in dialysis patients, file de3e52ae-b877-762d-e053-3705fe0a30e0
|
1
|
|
Nutritional status in hemodialysis patients: options for on-line convective treatment., file de3e52ae-b8fe-762d-e053-3705fe0a30e0
|
1
|
|
Emerging drugs for hyperphosphatemia, file de3e52ae-bed9-762d-e053-3705fe0a30e0
|
1
|
|
Erectile dysfunction in uremic dialysis patients: Diagnostic evaluation in the sildenafil era, file de3e52ae-c049-762d-e053-3705fe0a30e0
|
1
|
|
Hypertension in dialysis patients, file de3e52ae-c1bf-762d-e053-3705fe0a30e0
|
1
|
|
Newer aspects of carnitine metabolism in uremia, file de3e52ae-c500-762d-e053-3705fe0a30e0
|
1
|
|
Development of the concept of pain in history., file de3e52ae-cda7-762d-e053-3705fe0a30e0
|
1
|
|
Unexpected effect of ANTI-TNF therapy in Membranous Glomerulonephritis, file de3e52ae-e650-762d-e053-3705fe0a30e0
|
1
|
|
ANTI-TNFa THERAPY IN MEMBRANOUS GLOMERULONEPHRITIS, file de3e52ae-e6e1-762d-e053-3705fe0a30e0
|
1
|
|
Nutritional status in hemodialysis patients:options for on-line convective treatment, file de3e52ae-e7af-762d-e053-3705fe0a30e0
|
1
|
|
Carnitine and hemodialysis, file de3e52ae-e7b2-762d-e053-3705fe0a30e0
|
1
|
|
Phosphorus and bone disease, file de3e52ae-ee96-762d-e053-3705fe0a30e0
|
1
|
|
RENAL DISEASE IN ADULT PATIENTS WITH CYSTIC FIBROSIS, file de3e52ae-fad7-762d-e053-3705fe0a30e0
|
1
|
|
Drug-induced TINU syndrome and genetic characterization., file de3e52af-dbcb-762d-e053-3705fe0a30e0
|
1
|
|
New pharmacoeconomic option in uremic anemia management, file de3e52b0-4337-762d-e053-3705fe0a30e0
|
1
|
|
The management of kidney stones as suggested by Goeury-Duvivier, file de3e52b0-43d4-762d-e053-3705fe0a30e0
|
1
|
|
Evolution of the classification of acute and chronic transplant rejection, file de3e52b0-44dd-762d-e053-3705fe0a30e0
|
1
|
|
HLA haplotype in a patient with systemic lupus erythematosus triggered by hepatitis B vaccine, file de3e52b0-d485-762d-e053-3705fe0a30e0
|
1
|
| Totale |
100 |